Pharma Links 2014-04-18

http://pharma.about.com/b/2014/04/17/viagra-use-associated-with-melanoma-risk.htm
http://pharma.about.com/b/2014/04/11/report-specialty-drugs-driving-increase-in-drug-spending.htm
http://pharma.about.com/b/2014/03/31/ada-supports-research-of-cavity-preventing-chewing-gum.htm
http://pharma.about.com/b/archives.htm
http://pharma.about.com/b/
http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Pharma-Software-and-Clinical-IT-Websites.htm
http://pharma.about.com/od/DrugBasics/tp/Drugs-Used-in-Dental-Care.htm
http://pharma.about.com/od/SalesandMarketing/tp/The-7-Most-Expensive-Prescription-Drugs.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/Fastest-Growing-Pharmaceutical-Companies-2013.htm
http://pharma.about.com/od/BigPharma/tp/Top-Lay-offs-in-the-Pharmaceutical-Industry-in-2013.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/PharmaNewsSites.01.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/PharmaNewsSites.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Branded-Drug-Sales-For-2011.htm
http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Multiple-Sclerosis-Drugs.htm
http://pharma.about.com/b/2014/03/31/statins-might-aid-erectile-dysfunction.htm
http://pharma.about.com/b/2014/03/31/neos-therapeutics-meets-fundraising-target-for-time-release-technology.htm
http://pharma.about.com/od/B/g/Biologic-License-Application-Bla.htm
http://pharma.about.com/od/FDA/a/2012-Renewal-Of-The-Prescription-Drug-User-Fee-Act-Pdufa.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Pharma-Apps-For-Ipad-And-Mobiles.htm
http://pharma.about.com/od/T/
http://pharma.about.com/od/T/fl/Time-Release-Technology.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_3.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_5.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_6.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_4.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Emerging-Pharmaceutical-Markets_2.htm
http://pharma.about.com/od/DrugBasics/
http://pharma.about.com/od/E/
http://pharma.about.com/od/D/
http://pharma.about.com/od/Glossary/
http://pharma.about.com/od/N/
http://pharma.about.com/od/O/
http://pharma.about.com/b/2014/03/31/study-older-blood-pressure-drug-aids-heart-attack-patients.htm
http://pharma.about.com/b/2014/03/31/aan-offers-evidence-based-recommendation-on-cannabis-for-ms-pain.htm
http://pharma.about.com/b/2014/03/31/health-social-site-chatter-more-critical-of-drugs-than-google-twitter.htm
http://pharma.about.com/b/2014/03/31/europe-issues-recs-for-managing-drug-resistant-tb.htm
http://pharma.about.com/b/2014/03/24/fda-approves-impavido-for-infectious-disease-spread-by-sand-flies.htm
http://pharma.about.com/od/Research-and-Development/a/Which-Pharmas-Spend-The-Most-On-Randd.htm
http://pharma.about.com/b/2014/03/13/fda-warns-indian-api-manufacturer.htm
http://pharma.about.com/b/2014/03/21/social-media-marketing-for-pharmas-conference-planned.htm
http://pharma.about.com/b/2013/02/28/groups-combat-industry-influence-on-medical-school-campuses.htm
http://pharma.about.com/b/2012/11/30/new-version-of-dsm-to-be-voted-on-this-weekend.htm
http://pharma.about.com/od/Advertising/
http://pharma.about.com/od/Profiles/
http://pharma.about.com/od/Research-and-Development/
http://pharma.about.com/od/SalesandMarketing/
http://pharma.about.com/od/Manufacturing-and-Technology/fl/A-Social-Media-Strategy-for-Pharmas.htm
http://pharma.about.com/b/2014/02/28/fda-evaluates-safety-of-2-approve-testosterone-drugs.htm
http://pharma.about.com/od/BigPharma/tp/Big-Ten-Branded-Drug-Blockbusters-Of-2010.htm
http://pharma.about.com/od/BigPharma/tp/Big-Pharmas-Merger-Mania.htm
http://pharma.about.com/od/Glossary/fl/Pharmacogenomics.htm
http://pharma.about.com/od/P/fl/Pellicle.htm
http://pharma.about.com/od/Research-and-Development/fl/Pharmas-and-Cannabis-Drug-Research.htm
http://pharma.about.com/od/DrugBasics/fl/Do-Prescription-Drug-Scripts-Need-an-Overhaul.htm
http://pharma.about.com/od/DrugBasics/fl/Prescription-Drug-Naming-Conventions.htm
http://pharma.about.com/od/Government_IP/fl/FDA-and-EMA-Collaborate-on-Generic-Drug-Facility-Inspections.htm
http://pharma.about.com/od/Sales_and_Marketing/fl/Trends-in-Pediatric-ADHD-Medication-Sales.htm
http://pharma.about.com/od/C/g/Contract-Research-Organization-cro.htm
http://pharma.about.com/od/Clinical-Trials/fl/Declaration-of-Helsinki-Updated-on-50th-Anniversary.htm
http://pharma.about.com/od/T/g/Translational-Research.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-Rise-Of-Lifestyle-Drugs.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-Most-Prescribed-Medications-By-Drug-Class.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Data-Mining-Doctors-Prescribing-History.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Physician-Attitudes-Toward-Industry-Marketing.htm
http://pharma.about.com/od/B/fl/Blockbuster-Drug.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Pharma-Ad-Spending-On-Emerging-Markets-Digital.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Bioequivalence-Issues-In-The-News.htm
http://pharma.about.com/od/Manufacturing-and-Technology/fl/Pharma-and-Environmental-Policies.htm
http://pharma.about.com/od/Research-and-Development/a/The-Addiction-Medications-Tool-Chest.htm
http://pharma.about.com/od/Insurance-and-Medicare/i/Negotiating-Part-D.htm
http://pharma.about.com/od/Insurance-and-Medicare/i/Negotiating-Part-D_2.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013-Part-2_4.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_8.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_7.htm
http://pharma.about.com/od/Government_IP/i/Gene-Patents_2.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013-Part-2_5.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_6.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_9.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_16.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013-Part-2_3.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013-Part-2_2.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013-Part-2.htm
http://pharma.about.com/od/Government_IP/i/Gene-Patents.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013-Part-2_6.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_5.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_10.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_11.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_15.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_12.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_14.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_17.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_18.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_19.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_13.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_4.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_3.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013-Part-2_7.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013-Part-2_8.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_20.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013-Part-2_9.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013_2.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_7.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_10.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_11.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_3.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_4.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_5.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_6.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_8.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_9.htm
http://pharma.about.com/od/FDA/ss/The-27-New-Drugs-Approved-by-the-FDA-in-2013.htm
http://pharma.about.com/od/BigPharma/ss/The-Top-10-Pharma-Settlements_2.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Animal-Health-Drug-Companies_8.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_2.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_4.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_6.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_7.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_8.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_9.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Animal-Health-Drug-Companies.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Animal-Health-Drug-Companies_2.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Animal-Health-Drug-Companies_3.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Animal-Health-Drug-Companies_9.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Animal-Health-Drug-Companies_4.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Animal-Health-Drug-Companies_5.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Animal-Health-Drug-Companies_7.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_10.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_5.htm
http://pharma.about.com/od/Research-and-Development/ss/Funny-Research-Bloopers-Tweets-and-Easter-Eggs_8.htm
http://pharma.about.com/od/Research-and-Development/ss/Funny-Research-Bloopers-Tweets-and-Easter-Eggs_7.htm
http://pharma.about.com/od/Research-and-Development/ss/Funny-Research-Bloopers-Tweets-and-Easter-Eggs_6.htm
http://pharma.about.com/od/Research-and-Development/ss/Funny-Research-Bloopers-Tweets-and-Easter-Eggs_5.htm
http://pharma.about.com/od/Research-and-Development/ss/Funny-Research-Bloopers-Tweets-and-Easter-Eggs_4.htm
http://pharma.about.com/od/Research-and-Development/ss/Funny-Research-Bloopers-Tweets-and-Easter-Eggs_3.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome_3.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Pharma-Ads-When-In-Rome.htm
http://pharma.about.com/od/Research-and-Development/ss/Funny-Research-Bloopers-Tweets-and-Easter-Eggs.htm
http://pharma.about.com/od/Research-and-Development/ss/Funny-Research-Bloopers-Tweets-and-Easter-Eggs_2.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Top-Animal-Health-Drug-Companies_6.htm
http://pharma.about.com/od/B/g/A-Definition.htm
http://pharma.about.com/od/C/g/Current-Good-Manufacturing-Practices-Cgmps.htm
http://pharma.about.com/od/D/g/Drug-Master-File-Dmf.htm
http://pharma.about.com/od/D/g/Definition-Of-Double-blind-Trial.htm
http://pharma.about.com/od/P/g/Peer-Review.htm
http://pharma.about.com/od/O/g/Orphan-Drugs.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_4.htm
http://pharma.about.com/od/B/g/Bioequivalence.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_3.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_2.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads.htm
http://pharma.about.com/od/B/g/Bioavailability.htm
http://pharma.about.com/od/B/g/Biosafety-Levels.htm
http://pharma.about.com/od/N/g/National-Drug-Code-Ndc.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_5.htm
http://pharma.about.com/od/Sales_and_Marketing/ss/Vintage-Medicine-Ads_6.htm
http://pharma.about.com/od/A/g/Api-Active-Pharmaceutical-Ingredient.htm
http://pharma.about.com/od/A/g/Adverse-Event-Reporting-Aer.htm
http://pharma.about.com/od/N/g/New-Drug-Application-Nda.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-Changing-Face-Of-The-Anti-Depressant-Drug-Market.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-Smoking-Cessation-Drug-Market.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Direct-to-consumer-Advertising.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Survey-Its-Common-For-U-s-Medical-Students-To-Receive-Industry-Gifts.htm
http://pharma.about.com/od/Sales_and_Marketing/a/How-Is-The-The-Patent-Cliff-Affecting-The-Drug-Industry.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Emerging-Markets-Growing-By-Double-Digits-In-Annual-Health-Spending.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Study-Younger-Physicians-More-Skeptical-Of-Vaccines.htm
http://pharma.about.com/od/Sales_and_Marketing/a/What-Strategies-Can-A-Pharma-Marketer-Use-To-Reach-Doctors.htm
http://pharma.about.com/od/Sales_and_Marketing/u/Markets.htm
http://pharma.about.com/od/C/
http://pharma.about.com/od/Sales_and_Marketing/a/Anti-Obesity-Drug-Market-Trends_2.htm
http://pharma.about.com/od/Sales_and_Marketing/a/The-China-Pharmaceutical-Market.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Anti-Obesity-Drug-Market-Trends.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Pharmaceutical-Companies-Test-Opportunities-In-Russia.htm
http://pharma.about.com/od/O/g/Orange-Book.htm
http://pharma.about.com/od/B/g/Biobetter.htm
http://pharma.about.com/od/B/g/Biogeneric-Drugs.htm
http://pharma.about.com/od/A/g/Authorized-Generic-Definition.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/a/The-Over-the-counter-Drug-Industry.htm
http://pharma.about.com/od/A/
http://pharma.about.com/od/Over-the-Counter-Medicine/a/Top-selling-Otc-Drugs-By-Category-2012.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/
http://pharma.about.com/od/M/
http://pharma.about.com/od/DrugBasics/a/What-Were-Some-Of-The-Most-Important-Drug-Discoveries.htm
http://pharma.about.com/od/DrugBasics/a/Drugs-101-What-Is-A-Drug.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/a/Behind-The-Counter-Drugs.htm
http://pharma.about.com/od/Insurance-and-Medicare/a/Specialty-Pharmacies.htm
http://pharma.about.com/od/Insurance-and-Medicare/a/Medicare-Waste-And-Monitoring.htm
http://pharma.about.com/od/Insurance-and-Medicare/
http://pharma.about.com/od/Insurance-and-Medicare/a/Government-Health-Plans-And-The-Pharmaceutical-Industry.htm
http://pharma.about.com/od/Clinical-Trials/a/Check-In-On-The-Male-Contraceptive-Research.htm
http://pharma.about.com/od/Clinical-Trials/a/Clinical-Trials-Phases.htm
http://pharma.about.com/od/Clinical-Trials/a/Europe-Tiptoes-Towards-Publication-Of-Raw-Clinical-Trial-Data.htm
http://pharma.about.com/od/Clinical-Trials/a/Making-Clinical-Trials-Data-More-Transparent.htm
http://pharma.about.com/od/Clinical-Trials/a/Nida-Backs-Research-Of-Potential-Meth-Addiction-Drug.htm
http://pharma.about.com/od/Clinical-Trials/a/Opportunities-And-Challenges-Of-Pediatric-Clinical-Drug-Trials.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Best-Biotechs-And-Pharmas-To-Work-For.htm
http://pharma.about.com/od/Clinical-Trials/a/Where-Do-We-Stand-On-Comparative-Effectiveness-Research.htm
http://pharma.about.com/od/Clinical-Trials/a/The-Vaccine-Development-Process.htm
http://pharma.about.com/od/Research-and-Development/a/Drugs-To-Target-Circadian-Rhythm.htm
http://pharma.about.com/od/Research-and-Development/a/diabetespipeline.htm
http://pharma.about.com/od/Research-and-Development/a/A-Paradigm-Shift-In-Alzheimers-Diagnosis.htm
http://pharma.about.com/od/Research-and-Development/a/Hiv-Aids-Drug-Market.htm
http://pharma.about.com/od/Research-and-Development/a/Arms-New-Drugs-Could-Tease-Out-Antibodies-To-Fight-Infections-Cancer.htm
http://pharma.about.com/od/Research-and-Development/a/Tuberculosis-Drug-Discovery-Advances.htm
http://pharma.about.com/od/Research-and-Development/a/Un-Says-New-Drugs-Are-Winning-The-War-On-Aids.htm
http://pharma.about.com/od/Research-and-Development/a/European-Researchers-Re-purpose-Drugs-For-Ms.htm
http://pharma.about.com/od/Clinical-Trials/a/Rating-Clinical-Trials.htm
http://pharma.about.com/od/Clinical-Trials/
http://pharma.about.com/od/FDA/a/Firms-Make-Fda-Adverse-Event-Report-Data-Accessible.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2012.htm
http://pharma.about.com/od/Research-and-Development/u/Innovations.htm
http://pharma.about.com/od/FDA/a/All-About-Viibryd.htm
http://pharma.about.com/od/FDA/a/Encouraging-Rare-Diseases-Products-Development.htm
http://pharma.about.com/od/Research-and-Development/a/Who-Funds-Biomedical-Research.htm
http://pharma.about.com/od/Research-and-Development/a/Addressing-The-Antibiotics-Crisis.htm
http://pharma.about.com/od/Research-and-Development/a/Alternatives-To-Warfarin-For-Stroke-Prevention.htm
http://pharma.about.com/od/Research-and-Development/a/What-Are-The-Elements-Of-A-Research-Article.htm
http://pharma.about.com/od/Research-and-Development/a/Pharmas-Still-Finding-New-Uses-For-Botulinum-Toxin.htm
http://pharma.about.com/od/Government_IP/a/Drug-Classifications.htm
http://pharma.about.com/od/Government_IP/a/Global-Treaty-On-Mercury-Reduction-Fans-Thimerosal-In-Vaccines-Debate.htm
http://pharma.about.com/od/Government_IP/a/How-Are-Annual-Fees-On-Prescription-Drug-Manufacturers-Assessed.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011_4.htm
http://pharma.about.com/od/Government_IP/a/Are-Pay-For-Delay-Settlements-History.htm
http://pharma.about.com/od/Government_IP/a/U-S-Supreme-Court-Upholds-Bulk-Of-Affordable-Care-Act.htm
http://pharma.about.com/od/Government_IP/a/India-Clamps-Down-On-Clinical-Trials-Oversight.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011_3.htm
http://pharma.about.com/od/Government_IP/a/U-s-india-Trade-Relations-Heat-Up-Over-Generic-Patent-Import-Issues.htm
http://pharma.about.com/od/Government_IP/a/U-S-Policy-On-Drug-Importation.htm
http://pharma.about.com/od/FDA/a/Diabetes-Drug-Approval-Process.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011_2.htm
http://pharma.about.com/od/FDA/a/Adverseevents-Inc.htm
http://pharma.about.com/od/FDA/a/New-Drugs-Approved-By-The-Fda-In-2011.htm
http://pharma.about.com/od/Government_IP/a/Phrma-Pushes-Fda-To-Allow-truthful-Off-label-Marketing.htm
http://pharma.about.com/od/Philanthropy/a/Pharmas-And-Corporate-Philanthropy.htm
http://pharma.about.com/od/Generics/a/Top-Generic-Drug-Companies.htm
http://pharma.about.com/od/Philanthropy/a/Pharma-Partners-Pledge-1-4-Billion-Annually-To-Eradicate-Tropic.htm
http://pharma.about.com/od/Generics/
http://pharma.about.com/od/Government_IP/a/Should-Pediatricians-Fire-Families-For-Refusing-Vaccines.htm
http://pharma.about.com/od/Government_IP/a/Hungary-Passes-Strict-Drug-Pricing-And-Promotion-Laws.htm
http://pharma.about.com/od/Government_IP/a/The-Patent-Reform-Act-Of-2011-And-The-Pharmaceutical-Industry.htm
http://pharma.about.com/od/Government_IP/a/Pharmas-And-The-Stop-Internet-Piracy-Act.htm
http://pharma.about.com/od/Philanthropy/
http://pharma.about.com/od/BigPharma/p/Teva-Pharmaceutical-Industries-Ltd.htm
http://pharma.about.com/od/BigPharma/a/Wikileaks-Cables-Show-Diplomats-Aggressively-Promote-Pharmaceutical-Industry.htm
http://pharma.about.com/od/BigPharma/p/Baxter-International-Inc.htm
http://pharma.about.com/od/BigPharma/p/Glaxosmithkline-Gsk.htm
http://pharma.about.com/od/BigPharma/a/Which-Popular-Drugs-Are-Going-Off-Patent-In-2013-2016.htm
http://pharma.about.com/od/BigPharma/u/Issues.htm
http://pharma.about.com/od/BigPharma/a/Side-Effects-Associated-With-Gardasil.htm
http://pharma.about.com/od/Government_IP/
http://pharma.about.com/b/2014/02/28/bayer-to-acquire-chinese-medicine-company.htm
http://pharma.about.com/od/Manufacturing-and-Technology/
http://pharma.about.com/b/2014/02/28/did-the-fda-break-whistleblower-laws.htm
http://pharma.about.com/b/2014/02/28/johnson-johnson-will-fight-1-2-billion-judgement.htm
http://pharma.about.com/b/2014/02/28/study-cancer-trials-suffering-from-lack-of-patient-participants.htm
http://pharma.about.com/od/BigPharma/
http://pharma.about.com/b/2014/02/25/danish-study-finds-link-between-acetaminophen-and-adhd.htm
http://pharma.about.com/b/2013/08/21/gsks-tivicay-approved-as-hiv-treatment.htm
http://pharma.about.com/b/2014/02/16/fda-questions-manufacturing-on-migraine-drug-application.htm
http://pharma.about.com/b/2011/06/08/dr-reddys-soon-to-be-a-household-name.htm
http://pharma.about.com/b/2011/12/18/pfizer-plans-to-keep-lipitor-customers-despite-loss-of-patent.htm
http://pharma.about.com/b/2012/10/30/after-2-years-of-patent-losses-some-pharmas-show-resilience.htm
http://pharma.about.com/b/2013/05/21/congress-to-re-authorize-animal-pharmaceutical-industry-user-fees.htm
http://pharma.about.com/od/P/
http://pharma.about.com/od/B/
http://pharma.about.com/od/FDA/
http://pharma.about.com/b/2014/01/31/duavee-for-hot-flashes-launches-feb-3.htm
http://pharma.about.com/b/2014/01/31/the-pills-are-too-damn-high.htm
http://pharma.about.com/b/2014/01/28/fda-cited-for-failure-to-remove-risks-from-animal-antibiotics.htm
http://pharma.about.com/b/2014/01/25/regulators-morning-after-pill-may-not-work-in-heavy-and-obese-women.htm
http://pharma.about.com/b/2014/01/24/indian-pharmas-say-new-regs-are-driving-trials-offshore.htm
http://pharma.about.com/b/2014/01/10/france-approves-cannabis-drug-for-multiple-sclerosis.htm
http://pharma.about.com/b/2014/01/07/pharmalive-com-pharmalot-med-ad-news-cease-publication.htm
http://pharma.about.com/b/2014/01/05/fda-stations-more-inspectors-in-china-india.htm
http://pharma.about.com/b/2013/12/31/fda-oks-cbd-for-childhood-epilepsy-study.htm
http://pharma.about.com/
http://pharma.about.com/od/
http://pharma.about.com/b/2013/04/30/explore-the-history-of-medicine-site.htm
http://pharma.about.com/b/2013/12/20/pharmas-turn-to-cloud-computing.htm
http://pharma.about.com/od/Generics/a/Generic-Drug-Launches.htm
http://pharma.about.com/od/Generics/a/Generic-Drug-Pipeline.htm
http://pharma.about.com/od/Over-the-Counter-Medicine/a/Over-The-Counter-Drugs-Theres-A-Recipe-For-That.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Pharmas-And-Fda-Inspections.htm
http://pharma.about.com/od/Clinical-Trials/a/Clinical-Trials-Training-Opportunities.htm
http://pharma.about.com/od/Manufacturing-and-Technology/a/Going-Green-Is-Good-For-Business.htm
http://pharma.about.com/od/Sales_and_Marketing/a/Pharmaceutical-Companies-Flock-To-Brazil.htm
http://pharma.about.com/od/FDA/a/Viibryd-First-New-Antidepressant-In-A-Decade.htm
http://pharma.about.com/od/Government_IP/a/Health-Care-Reform-Implementation-Schedule-For-Pharmas.htm
http://pharma.about.com/od/Government_IP/a/How-Are-Pharma-Companies-Preparing-For-Proposed-Changes-To-U-S-Health-Care.htm
http://pharma.about.com/od/Government_IP/a/Ip-Laws-And-Pharma.htm
http://pharma.about.com/od/O/g/Off-label-Promotion.htm
http://pharma.about.com/b/2012/09/26/pharma-topics-among-free-online-education-offerings.htm
http://pharma.about.com/b/2013/12/19/gsk-and-theravance-copd-drug-approved.htm
http://pharma.about.com/b/2013/12/18/pfizer-and-teva-agree-on-2017-release-for-generic-viagra.htm
http://pharma.about.com/b/2013/12/17/meat-from-horses-used-in-medical-research-allegedly-sold-as-food-in-france.htm
http://pharma.about.com/b/2013/12/17/denmark-based-lundbeck-says-new-alzheimers-drug-on-track-for-2017.htm
http://pharma.about.com/b/2013/12/17/bill-to-restrict-pay-for-delay-agreements-re-introduced.htm
http://pharma.about.com/b/2013/12/16/pharmas-roi-still-in-decline-despite-more-approvals.htm
http://pharma.about.com/b/2011/01/23/pharma-ad-spending-down-in-2010.htm
http://pharma.about.com/b/2011/01/14/india-adds-barcode-requirement-on-pharma-exports.htm
http://pharma.about.com/b/2012/08/30/solanezumab-trials-in-alzheimers-disease-continue.htm
http://pharma.about.com/b/2012/05/03/whos-tops-in-pharma-ceo-salaries.htm
http://pharma.about.com/b/2012/11/30/johnson-johnson-wont-enforce-hiv-drug-patent-in-africa.htm
http://pharma.about.com/b/2010/12/29/genetic-study-shows-how-50-year-old-drug-helps-people-with-diabetes.htm
http://pharma.about.com/b/2012/01/09/no-dissipation-of-controversy-over-hhs-decision-on-plan-b.htm
http://pharma.about.com/b/2013/12/16/eu-fines-drug-makers-for-blocking-sales-of-a-generic-painkiller.htm
http://pharma.about.com/b/2013/12/15/report-prescription-drug-spending-to-exceed-1t-in-2014.htm
http://pharma.about.com/b/2013/12/13/fda-approves-two-new-hep-c-drugs.htm
http://pharma.about.com/od/Sales_and_Marketing/
http://pharma.about.com/b/2013/11/30/u-of-toronto-researchers-develop-greener-drug-production-process.htm
http://pharma.about.com/b/2013/11/29/children-and-adhd-medication-trends.htm
http://pharma.about.com/b/2013/11/30/should-nurses-and-pharmacists-be-included-in-sunshine-act.htm
http://pharma.about.com/b/2013/11/30/study-billions-of-cancer-patients-suffer-due-to-over-regulation-of-pain-medicines.htm
http://pharma.about.com/b/2013/11/30/researchers-develop-nanoparticle-pill-delivery-system.htm
http://pharma.about.com/b/2013/11/25/closed-door-tpp-negotiations-involving-pharma-other-industries-spark-protests.htm
http://pharma.about.com/b/2013/11/18/study-questions-safety-of-fda-fast-track-approvals.htm
http://pharma.about.com/b/2013/11/06/disappointing-results-from-als-empower-trial-published.htm
http://pharma.about.com/b/2010/10/14/website-promotes-patient-adherance.htm
http://pharma.about.com/b/2010/11/19/pharmas-make-top-green-rankings.htm
http://pharma.about.com/b/2010/10/14/another-anti-obesity-hopeful-about-to-bite-the-dust.htm
http://pharma.about.com/b/2010/12/05/bare-truth-in-love-and-other-drugs.htm
http://pharma.about.com/b/2010/12/10/noose-tightens-on-rogue-online-pharmacies.htm
http://pharma.about.com/b/2010/12/14/patient-privacy-concerns-precede-smart-pills.htm
http://pharma.about.com/b/2010/12/20/pharmas-tops-in-settlements-paid-to-government.htm
http://pharma.about.com/b/2010/12/06/wikileaked-cable-lists-pharmas-vital-to-national-security.htm
http://pharma.about.com/b/2010/10/14/combat-mad-scientist-myth.htm
http://pharma.about.com/b/2011/03/07/collaborative-pharmas-and-union-workers-break-adversary-strereotypes.htm
http://pharma.about.com/b/2011/05/25/74-percent-and-growing-most-prescriptions-now-written-for-generic-drugs.htm
http://pharma.about.com/b/2011/01/09/fda-requires-addition-to-clinical-trial-informed-consent-documents.htm
http://pharma.about.com/b/2011/05/02/long-push-for-new-hepatitis-c-drugs-bears-fruit.htm
http://pharma.about.com/b/2011/05/11/check-up-on-insulin-pill-development.htm
http://pharma.about.com/b/2011/06/13/wisc-otc-manufacturer-distributor-face-fda-injunction.htm
http://pharma.about.com/b/2011/06/14/survey-most-americans-have-their-children-vaccinated-but-express-safety-concerns.htm
http://pharma.about.com/b/2011/06/27/researchers-keep-marketers-out-of-clinical-trial-process.htm
http://pharma.about.com/b/2011/07/07/european-austerity-budgets-target-pharmaceutical-pricing.htm
http://pharma.about.com/b/2011/08/01/johnson-johnson-to-phase-in-lower-dosing-of-tylenol-products.htm
http://pharma.about.com/b/2011/06/21/weighing-in-on-comparative-effectiveness-drug-trials.htm
http://pharma.about.com/b/2011/05/01/exhibit-hall-hijinks.htm
http://pharma.about.com/b/2011/04/30/pharmacy-researchers-drill-down-on-patient-adherence.htm
http://pharma.about.com/b/2011/02/28/fujifilm-and-samsung-stake-claim-on-biologics-future.htm
http://pharma.about.com/b/2011/03/25/oops-fda-new-drug-approvals-tally-excludes-biologics.htm
http://pharma.about.com/b/2011/03/27/human-gene-patents-in-limbo.htm
http://pharma.about.com/b/2011/04/11/obesity-drug-back-in-play-following-positive-trial-results.htm
http://pharma.about.com/b/2011/04/17/gsk-puts-alli-and-other-otc-drugs-on-the-block.htm
http://pharma.about.com/b/2011/04/28/managed-care-pharmacists-keep-ahead-of-the-curve.htm
http://pharma.about.com/b/2011/04/30/embryonic-stem-cell-research-allowed-to-proceed-again.htm
http://pharma.about.com/b/2011/08/13/fda-approves-complera-a-daily-pill-for-hiv.htm
http://pharma.about.com/b/2011/08/28/canadian-pharmacy-us-seniors-groups-seek-alternative-to-blanket-ban-on-canadian-online-drug-advertising.htm
http://pharma.about.com/b/2011/09/10/atrial-fib-drugs-multaq-experience-may-make-it-harder-to-approve-xarelto.htm
http://pharma.about.com/b/2011/08/17/industry-grows-restless-waiting-for-fdas-social-media-guidance.htm
http://pharma.about.com/b/2011/08/09/fda-to-address-drug-shortages.htm
http://pharma.about.com/b/2011/08/07/glaxosmithklines-iraq-deal.htm
http://pharma.about.com/b/2011/08/06/pharma-exec-industry-consolidation-hurts-drug-research.htm
http://pharma.about.com/b/2011/10/10/infectious-disease-experts-wanted-new-drugs-now-they-have-them.htm
http://pharma.about.com/b/2011/08/29/fda-lower-maximum-daily-dose-of-celexa-to-protect-heart.htm
http://pharma.about.com/b/2011/09/10/a-dozen-pharmas-make-payments-to-physicians-public.htm
http://pharma.about.com/b/2011/11/20/fda-revokes-approval-of-avastin-for-breast-cancer.htm
http://pharma.about.com/b/2011/11/28/defense-department-issues-rfps-for-antibiotic-alternatives.htm
http://pharma.about.com/b/2011/10/26/analysis-of-flu-vaccines-finds-effectiveness-falls-short-of-claims.htm
http://pharma.about.com/b/2011/09/30/pharmaceutical-exec-blames-fda-inspections-for-drug-shortages.htm
http://pharma.about.com/b/2011/09/26/pfizer-expands-its-biomanufacturing-plant-in-ireland.htm
http://pharma.about.com/b/2011/11/07/xarelto-approved-for-stroke-prevention.htm
http://pharma.about.com/b/2011/11/01/study-biomedical-research-papers-have-too-many-innapropriate-authors.htm
http://pharma.about.com/b/2011/10/31/fda-tempers-viibryd-expectations-in-journal-article.htm
http://pharma.about.com/b/2011/10/17/harvard-medical-school-to-apply-systems-approach-to-drug-discovery.htm
http://pharma.about.com/b/2011/09/12/another-new-medical-use-for-botulinum-toxin.htm
http://pharma.about.com/b/2011/09/13/pres-obama-to-sign-patent-reform-law-sept-16.htm
http://pharma.about.com/b/2011/11/22/fujifilm-takes-bigger-role-in-biosimilar-development.htm
http://pharma.about.com/b/2011/09/13/supreme-court-sets-date-to-hear-mayo-prometheus-patents-case.htm
http://pharma.about.com/b/2011/10/24/infectious-disease-experts-analyze-physician-views-on-vaccines.htm
http://pharma.about.com/b/2011/09/16/nih-to-facilitate-bench-to-bedside-license-agreements-for-start-up-companies.htm
http://pharma.about.com/b/2011/12/01/clinicaltrials-gov-still-amazes.htm
http://pharma.about.com/b/2011/12/31/procolor-biotech-pursuing-biobetter-for-growth-hormone-deficiencies.htm
http://pharma.about.com/b/2011/12/26/fda-approved-hangover-remedy-ready-for-new-years.htm
http://pharma.about.com/b/2012/03/18/takedas-new-diabetes-drug-reduces-hypoglycemia-risk-in-phase-2-trial.htm
http://pharma.about.com/b/2012/03/11/study-antipsychotic-haloperidol-raises-mortality-risk-in-nursing-homes.htm
http://pharma.about.com/b/2012/02/22/fda-to-review-aeroshot-an-inhaleable-caffeine.htm
http://pharma.about.com/b/2012/02/22/pharma-employment-still-taking-hits.htm
http://pharma.about.com/b/2012/02/22/fda-panel-votes-20-2-to-approve-qnexa-for-weight-loss.htm
http://pharma.about.com/b/2012/02/16/informed-consent-documents-revised-for-clinical-trials.htm
http://pharma.about.com/b/2012/03/12/protein-could-be-possible-target-for-obesity-drugs.htm
http://pharma.about.com/b/2012/02/16/fda-counterfeit-avastin-found-in-three-states.htm
http://pharma.about.com/b/2012/01/09/novartis-recalls-some-popular-otc-drugs.htm
http://pharma.about.com/b/2012/01/10/fda-to-send-recommendations-on-biosimilar-user-fees-to-congress.htm
http://pharma.about.com/b/2012/01/28/viibryd-and-bystolic-help-forest-labs-exceed-sales-projections.htm
http://pharma.about.com/b/2012/01/13/dissecting-fdas-draft-guidance-on-mobile-medical-apps.htm
http://pharma.about.com/b/2012/02/08/immunization-schedule-updates-for-children-and-adults-published.htm
http://pharma.about.com/b/2012/01/13/fast-tracked-cancer-drug-implicated-in-brain-inflammation-in-3-patients.htm
http://pharma.about.com/b/2012/01/13/fda-cancer-drug-shortages-price-tags-encourage-counterfeits.htm
http://pharma.about.com/b/2012/01/14/cdc-fatal-prescription-drug-overdose-rate-tripled-since-1990.htm
http://pharma.about.com/b/2012/01/28/fda-approves-btgs-biologics-license-application-bla-for-voraxaze.htm
http://pharma.about.com/b/2012/01/09/study-newly-identified-compound-could-prevent-sudden-heat-stroke.htm
http://pharma.about.com/b/2012/01/23/pharma-whistleblower-story-gets-picked-up-by-film-producer.htm
http://pharma.about.com/b/2011/12/31/wikileaks-cable-haunted-pfizer-in-2011.htm
http://pharma.about.com/b/2012/05/02/three-new-ms-drugs-could-reach-the-market-in-2012-13.htm
http://pharma.about.com/b/2012/05/12/researchers-fool-opioid-receptors-into-strengthening-immune-system.htm
http://pharma.about.com/b/2012/03/20/supreme-court-rules-prometheus-patents-law-of-nature-and-invalid.htm
http://pharma.about.com/b/2012/05/14/lenalidomide-improved-outcomes-for-multiple-myeloma-after-stem-cell-transplants.htm
http://pharma.about.com/b/2012/04/30/many-reasons-for-gardasils-slow-sales.htm
http://pharma.about.com/b/2012/05/28/fda-approves-11-generics-for-plavix.htm
http://pharma.about.com/b/2012/03/26/eli-lilly-to-introduce-a-dozen-plus-products-in-china.htm
http://pharma.about.com/b/2012/05/01/antibiotic-approved-to-treat-and-prevent-plague.htm
http://pharma.about.com/b/2012/04/29/fda-to-co-sponsor-industry-cgmp-conference.htm
http://pharma.about.com/b/2012/06/30/study-use-bodys-immune-response-to-limit-tb-bacteria-growth.htm
http://pharma.about.com/b/2012/06/27/eli-lilly-launches-diagnostic-tracer-for-alzheimers-disease.htm
http://pharma.about.com/b/2012/06/23/nhs-accuses-pharmas-of-creating-drug-shortages.htm
http://pharma.about.com/b/2012/04/24/collaboration-or-just-good-timing.htm
http://pharma.about.com/b/2012/04/23/review-of-adverse-events-finds-little-risk-in-herpes-zoster-shingles-vaccine.htm
http://pharma.about.com/b/2012/04/06/researchers-vast-majority-of-preclinical-cancer-studies-not-reproducible.htm
http://pharma.about.com/b/2012/04/02/phase-3-trial-tevas-laquinimod-reduces-progression-of-relapsing-ms.htm
http://pharma.about.com/b/2012/06/10/anticoagulants-lead-in-adverse-event-reports.htm
http://pharma.about.com/b/2012/05/31/senate-rejects-effort-to-relax-drug-importation-rules.htm
http://pharma.about.com/b/2012/05/28/revlimid-associated-with-secondary-cancers.htm
http://pharma.about.com/b/2012/06/17/computer-model-may-help-weed-out-unsafe-drugs.htm
http://pharma.about.com/b/2012/04/30/drugs-approved-for-pediatric-use.htm
http://pharma.about.com/b/2012/08/26/pharmas-making-up-some-losses-in-emerging-markets.htm
http://pharma.about.com/b/2012/09/06/anti-obesity-pill-qsymia-to-reach-market-in-4th-quarter.htm
http://pharma.about.com/b/2012/09/15/french-doctors-claim-half-of-prescription-drugs-are-useless.htm
http://pharma.about.com/b/2012/09/26/merck-no-longer-has-budget-to-support-alec.htm
http://pharma.about.com/b/2012/09/28/more-addiction-drugs-are-entering-the-pipeline.htm
http://pharma.about.com/b/2012/09/29/deluge-of-inquiries-follow-article-on-addiction-medication.htm
http://pharma.about.com/b/2012/09/30/depomed-files-suit-against-fda-over-orphan-drug-status.htm
http://pharma.about.com/b/2012/09/30/judging-a-company-by-the-way-they-treat-their-postdocs.htm
http://pharma.about.com/b/2012/09/30/know-your-health-care-bureaucracy.htm
http://pharma.about.com/b/2012/09/30/new-technologies-spur-global-api-market-growth.htm
http://pharma.about.com/b/2012/10/01/mit-researchers-propose-megafund-for-cancer-drug-discovery.htm
http://pharma.about.com/b/2012/08/31/under-generic-drug-act-cros-must-log-company-details-with-the-fda.htm
http://pharma.about.com/b/2012/07/16/half-of-london-olympics-athletes-will-undergo-drug-testing-at-gsk-anti-doping-lab.htm
http://pharma.about.com/b/2012/07/30/companies-release-new-clinical-trials-results.htm
http://pharma.about.com/b/2012/07/17/will-new-branded-prescription-drug-fee-drive-up-costs.htm
http://pharma.about.com/b/2012/07/25/eu-regulators-cracking-down-on-pay-for-delay.htm
http://pharma.about.com/b/2012/07/11/fda-opioid-makers-must-provide-safe-use-training-to-prescribers.htm
http://pharma.about.com/b/2012/07/31/drug-abuse-through-the-ages.htm
http://pharma.about.com/b/2012/08/04/fda-approves-sanofis-colon-cancer-drug.htm
http://pharma.about.com/b/2012/08/10/wto-seeks-international-aid-for-syrias-severe-drug-shortages.htm
http://pharma.about.com/b/2012/08/11/ftc-approves-drug-shortages-plan.htm
http://pharma.about.com/b/2012/08/20/emerging-market-slowdown.htm
http://pharma.about.com/b/2012/08/24/legislator-seeks-coordination-on-autoimmune-disease-research-therapy.htm
http://pharma.about.com/b/2012/07/18/british-athletes-promote-drug-free-winning-in-gsks-olympic-ads.htm
http://pharma.about.com/b/2012/11/30/male-birth-control-pill-due-soon.htm
http://pharma.about.com/b/2012/11/30/russias-pharma-industry-suffering-from-administrative-pains.htm
http://pharma.about.com/b/2012/12/18/lorus-therapeutics-and-brock-university-proceed-with-plant-based-cancer-therapy.htm
http://pharma.about.com/b/2012/11/24/international-directory-of-pharmas-published.htm
http://pharma.about.com/b/2012/12/18/rapid-economic-growth-drives-africa-drug-market.htm
http://pharma.about.com/b/2012/10/31/aers-data-shows-viibryd-post-market-adverse-events-consistent-with-clinical-trials-outcomes.htm
http://pharma.about.com/b/2012/10/31/fda-releases-draft-guidance-for-dmf-submissions.htm
http://pharma.about.com/b/2012/11/04/drug-crisis-in-greece-deepens.htm
http://pharma.about.com/b/2012/11/26/unaids-will-host-google-hangout-on-november-27.htm
http://pharma.about.com/b/2012/11/24/under-fda-review-insomnia-drug-that-minimizes-grogginess.htm
http://pharma.about.com/b/2012/10/31/mini-poll-pfizers-social-media-presence-is-strongest.htm
http://pharma.about.com/b/2012/12/23/new-hep-c-drug-increases-risk-of-serious-skin-reactions.htm
http://pharma.about.com/b/2012/12/29/ga-researchers-canine-virus-may-be-useful-for-human-vaccine-delivery.htm
http://pharma.about.com/b/2013/01/10/pharmas-report-flu-drug-shortages.htm
http://pharma.about.com/b/2013/01/28/takeda-pharmaceuticals-gets-a-triple-play-with-new-type-2-diabetes-drug-approvals.htm
http://pharma.about.com/b/2013/01/21/cdc-multi-resitant-tb-drugs-in-short-supply-for-years.htm
http://pharma.about.com/b/2013/01/01/pharmas-doing-business-in-australia-to-disclose-physician-payments.htm
http://pharma.about.com/b/2012/10/05/fda-withdraws-approval-of-tevas-budeprion-xl-300-mg-citing-lack-of-bioequivalency.htm
http://pharma.about.com/b/2012/12/31/un-body-to-take-up-draft-treaty-on-mercury-including-a-ban-on-thimerosal-in-vaccines.htm
http://pharma.about.com/b/2012/10/14/are-pharmas-planning-to-offshore-more-jobs.htm
http://pharma.about.com/b/2012/12/30/pharmas-rush-to-pay-investor-dividends-before-tax-increase.htm
http://pharma.about.com/b/2012/10/28/study-glaucoma-drug-helps-balding-men-regrow-hair.htm
http://pharma.about.com/b/2012/10/31/ad-companies-say-pharma-spending-is-down.htm
http://pharma.about.com/b/2012/12/30/eliquis-approved-for-reduction-of-stroke-risk-in-patients-with-atrial-fibrillation.htm
http://pharma.about.com/b/2013/02/25/dtc-campaign-planned-for-new-arthritis-drug.htm
http://pharma.about.com/b/2013/02/21/vaccine-infographic-tells-the-story.htm
http://pharma.about.com/b/2013/03/31/ketamine-explored-as-suicide-prevention-drug.htm
http://pharma.about.com/b/2013/03/31/study-varenicline-improves-smokers-chances-of-quitting.htm
http://pharma.about.com/b/2013/02/05/uk-physicians-and-med-students-object-to-bad-guidelines.htm
http://pharma.about.com/b/2013/02/02/amgen-fires-back-on-criticism-of-special-congressional-treatment.htm
http://pharma.about.com/b/2013/04/30/tax-breaks-for-baxter-healthcare-riles-some-minn-legislators.htm
http://pharma.about.com/b/2013/01/30/two-groups-to-host-specialty-pharmacy-conference.htm
http://pharma.about.com/b/2013/01/31/mercks-oxytrol-patch-for-overactive-bladder-approved-for-otc.htm
http://pharma.about.com/b/2013/04/28/actavis-settles-with-purdue-pharma-will-market-generic-oxycontin-pending-fda-approval.htm
http://pharma.about.com/b/2013/01/31/scientists-resume-work-on-h5n1-avian-flu-virus.htm
http://pharma.about.com/b/2013/04/13/generic-drug-prices-start-to-fall-in-canadian-provinces.htm
http://pharma.about.com/b/2013/02/19/phrma-will-fight-rebates-for-low-income-drug-beneficiaries.htm
http://pharma.about.com/b/2013/01/31/pfizer-continues-to-scale-back-rd-investment.htm
http://pharma.about.com/b/2013/02/26/fda-approves-third-drug-to-treat-gastrointestinal-tumors.htm
http://pharma.about.com/b/2013/03/24/gop-legislators-propose-an-fda-oversight-board.htm
http://pharma.about.com/b/2013/03/22/supreme-court-to-hear-pay-for-delay-arguments.htm
http://pharma.about.com/b/2013/04/01/novartis-says-indian-patent-ruling-will-discourage-future-investment.htm
http://pharma.about.com/b/2013/03/31/consumer-reports-finds-wide-gaps-in-pharmacy-generic-pricing.htm
http://pharma.about.com/b/2013/03/19/founder-of-generic-powerhouse-dr-reddys-passed-away.htm
http://pharma.about.com/b/2013/03/10/ncats-making-old-and-abandoned-drugs-a-starting-point-for-new-therapies.htm
http://pharma.about.com/b/2013/02/28/when-flaws-escape-the-peer-reviewers.htm
http://pharma.about.com/b/2013/04/22/fda-failed-to-act-on-faulty-drug-research.htm
http://pharma.about.com/b/2013/07/04/eu-portal-for-chemotherapy-collaboration-goes-live.htm
http://pharma.about.com/b/2013/06/27/study-adhd-drug-improves-brain-function-in-cocaine-addicts.htm
http://pharma.about.com/b/2013/06/07/recent-hits-and-misses-in-oncology-medications.htm
http://pharma.about.com/b/2013/06/27/guidelines-issued-on-use-of-anticoagulants-by-cerebrovascular-patients-during-surgical-procedures.htm
http://pharma.about.com/b/2013/06/27/bought-film-will-target-big-pharma-marketing-and-lobbying-practices.htm
http://pharma.about.com/b/2013/06/08/hhs-funds-more-gsk-antibiotic-research.htm
http://pharma.about.com/b/2013/06/30/fda-offers-primer-on-animal-drug-development-process.htm
http://pharma.about.com/b/2013/05/26/report-affordable-care-act-a-huge-boon-for-pharmas.htm
http://pharma.about.com/b/2013/06/30/german-researchers-use-computer-modeling-to-predict-best-cancer-treatments.htm
http://pharma.about.com/b/2013/05/24/pharma-industry-seeks-end-to-off-label-marketing-restrictions.htm
http://pharma.about.com/b/2013/07/23/china-widens-pharma-corruption-investigation.htm
http://pharma.about.com/b/2013/07/31/hong-kong-angles-for-a-share-of-the-clinical-trials-market.htm
http://pharma.about.com/b/2013/07/31/how-the-orange-book-got-its-name.htm
http://pharma.about.com/b/2013/05/15/global-vaccine-use-surveillance-tool-tracks-public-perceptions.htm
http://pharma.about.com/b/2013/05/13/fda-approves-breo-ellipta-for-copd.htm
http://pharma.about.com/b/2013/05/07/pfizer-tackles-multiple-problems-by-selling-viagra-online.htm
http://pharma.about.com/b/2013/08/22/specialists-are-frustrated-over-persistent-drug-shortages.htm
http://pharma.about.com/b/2013/10/03/medical-research-disrupted-by-government-shutdown.htm
http://pharma.about.com/b/2013/09/30/ratings-service-pharma-losses-from-patent-cliff-overblown.htm
http://pharma.about.com/b/2013/10/31/tel-aviv-university-researchers-release-genetic-analysis-app.htm
http://pharma.about.com/b/2013/10/31/study-one-third-of-registered-trials-go-unpublished.htm
http://pharma.about.com/b/2013/10/13/the-value-of-advertising.htm
http://pharma.about.com/b/2013/10/20/compounding-quality-act-seeks-to-correct-constitutional-defect.htm
http://pharma.about.com/b/2013/10/30/brisdelle-for-menopause-to-hit-pharmacy-shelves-in-november.htm
http://pharma.about.com/b/2013/10/31/pharmacogenetics-and-the-future-of-psychiatric-drugs.htm
http://pharma.about.com/b/2013/09/18/hhs-invites-comments-on-adverse-events-prevention.htm
http://pharma.about.com/b/2013/09/16/fda-panel-recommends-approval-of-another-gsk-copd-drug.htm
http://pharma.about.com/b/2013/09/15/hard-numbers-on-pharma-campaign-donations.htm
http://pharma.about.com/b/2013/09/14/pharma-challenges-maines-drug-importation-law.htm
http://pharma.about.com/b/2013/09/13/malaria-vaccine-found-safe-in-early-trial.htm
http://pharma.about.com/b/2013/08/31/fda-panel-recommends-making-nasacort-aq-o-t-c.htm
http://pharma.about.com/b/2013/09/13/ethics-and-business-at-war-in-india-over-clinical-trials.htm
http://pharma.about.com/b/2013/09/08/should-university-drug-royalties-be-taxable.htm
http://pharma.about.com/b/2013/08/31/saudi-arabia-plans-to-reign-in-drug-prices.htm
http://pharma.about.com/b/2013/08/23/parsing-the-2013-pharmabiotech-ipo-stampede.htm
http://pharma.about.com/od/BigPharma/p/Pfizer.htm
http://pharma.about.com/od/C/g/Comparative-Effectiveness-Research-Cer.htm
http://pharma.about.com/od/B/g/Black-Box-Warning.htm
http://pharma.about.com/od/M/g/Medically-Necessary.htm
http://pharma.about.com/od/Government_IP/i/Preventing-Counterfeit-Drug-Trade_2.htm
http://pharma.about.com/od/Manufacturing-and-Technology/i/Drug-Shortages_2.htm
http://pharma.about.com/od/B/g/Background-Contamination.htm
http://pharma.about.com/od/P/g/Protein-Misfolding-Diseases.htm
http://pharma.about.com/od/BigPharma/tp/Top-U-S-Pharmas.htm
http://pharma.about.com/od/A/g/Abbreviated-New-Drug-Application.htm
http://pharma.about.com/od/Government_IP/u/Regulations.htm
http://pharma.about.com/od/Manufacturing-and-Technology/i/Drug-Shortages.htm
http://pharma.about.com/od/BigPharma/p/Johnson-And-Johnson-Jandj.htm
http://pharma.about.com/od/Government_IP/i/Preventing-Counterfeit-Drug-Trade.htm
http://pharma.about.com/b/a/200603.htm